ResearcherNanjing Drum Tower HospitalActive in the last 2 years
Xiao Fu
Matched on ORCID iD 0000-0003-2495-1583; OpenAlex author ID A5101615336. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 28
2020: 2 papers · 2021: 2 papers · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper
Papers 6
- SP1-Mediated Glycolytic Reprogramming Promotes Tumorigenesis and Progression in Pancreatic Cancer. Co-author DOI 10.1002/advs.202510071↗
- Christmas Tree-Shaped Microneedles as FOLFIRINOX Spatiotemporal Delivery System for Pancreatic Cancer Treatment. First author DOI 10.34133/2022/9809417↗
- Metabolic Rewiring by Loss of Sirt5 Promotes Kras-Induced Pancreatic Cancer Progression. Co-author DOI 10.1053/j.gastro.2021.06.045↗
- Zinc finger protein 91 accelerates tumour progression by activating β-catenin signalling in pancreatic cancer. Last author DOI 10.1111/cpr.13031↗
- MUC1 promotes glycolysis through inhibiting BRCA1 expression in pancreatic cancer. Co-author DOI 10.1016/s1875-5364(20)30019-4↗
- Mind Bomb 1 Promotes Pancreatic Cancer Proliferation by Activating β-Catenin Signaling. Co-author DOI 10.1166/jnn.2020.18755↗
Closest collaborators
The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Neng Tang · 4 shared papers, 2020–2025 · strength 0.64
- Paper SP1-Mediated Glycolytic Reprogramming Promotes Tumorigenesis and Progression in Pancreatic Cancer. DOI 10.1002/advs.202510071↗
- Paper Zinc finger protein 91 accelerates tumour progression by activating β-catenin signalling in pancreatic cancer. DOI 10.1111/cpr.13031↗
- Paper MUC1 promotes glycolysis through inhibiting BRCA1 expression in pancreatic cancer. DOI 10.1016/s1875-5364(20)30019-4↗
- Yudong Qiu · 3 shared papers, 2020–2025 · strength 0.49
- Paper SP1-Mediated Glycolytic Reprogramming Promotes Tumorigenesis and Progression in Pancreatic Cancer. DOI 10.1002/advs.202510071↗
- Paper Zinc finger protein 91 accelerates tumour progression by activating β-catenin signalling in pancreatic cancer. DOI 10.1111/cpr.13031↗
- Paper Mind Bomb 1 Promotes Pancreatic Cancer Proliferation by Activating β-Catenin Signaling. DOI 10.1166/jnn.2020.18755↗
- Yuanjin Zhao · 1 shared paper, 2022 · strength 0.22
- Danqing Huang · 1 shared paper, 2022 · strength 0.22
- Linxi Zhu · 1 shared paper, 2025 · strength 0.19
- Jiatong Tang · 1 shared paper, 2025 · strength 0.19
- Chao Yan · 1 shared paper, 2025 · strength 0.19
- Hexing Hang · 1 shared paper, 2025 · strength 0.19
- Qi Li · 1 shared paper, 2025 · strength 0.19
- Zhenghua Cai · 1 shared paper, 2025 · strength 0.19
- Hao Cheng · 1 shared paper, 2025 · strength 0.19
- Jian He · 1 shared paper, 2021 · strength 0.16
- Taiyu Song · 1 shared paper, 2021 · strength 0.16
- Yudong Qiu · 1 shared paper, 2020 · strength 0.15
- Kamiya Mehla · 1 shared paper, 2021 · strength 0.09
- Nicholas James Mullen · 1 shared paper, 2021 · strength 0.09
- Divya Murthy · 1 shared paper, 2021 · strength 0.09
- Tuo Hu · 1 shared paper, 2021 · strength 0.09
- Chunbo He · 1 shared paper, 2021 · strength 0.09
- Nina V. Chaika · 1 shared paper, 2021 · strength 0.09
- Scott E. Mulder · 1 shared paper, 2021 · strength 0.09
- Enza Vernucci · 1 shared paper, 2021 · strength 0.09
- Ryan J. King · 1 shared paper, 2021 · strength 0.09
- Ravi Kumar Thakur · 1 shared paper, 2021 · strength 0.09
- Pankaj Kumar Singh · 1 shared paper, 2021 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.